Abstract:Key points Low‐frequency (4–14 Hz, ‘theta’) neuronal oscillations are essential for various animal behaviours, and are strongly influenced by inhibitory neuronal activity, although the interneurons responsible for such activity are not known. We used optogenetic methods to identify the generators of cholinergically activated, theta‐frequency inhibitory postsynaptic currents (IPSCs) in mouse CA1 hippocampus. Rhythmic IPSCs are driven by the activation of muscarinic acetylcholine receptors (mAChRs) via mAChR agonist application or ACh release from cholinergic axons. The output of parvalbumin (PV)‐expressing interneurons was prevented optogenetically or pharmacologically without affecting mAChR‐dependent oscillatory IPSCs. Instead, these IPSCs were blocked by inhibiting interneurons that express glutamic acid decarboxylase 2 (Gad2) and cannabinoid receptors, primarily the cholecystokinin (CCK)‐expressing cells. Theta‐frequency IPSCs were also inhibited by a μ‐opioid receptor agonist, suggesting that, in addition to being a potential substrate for the generation of behaviourally important rhythms, the same interneurons are a site of convergence of the cannabinoid and opioid neuromodulatory systems. Abstract Neuronal electrical oscillations in the theta (4–14 Hz) and gamma (30–80 Hz) ranges are necessary for the performance of certain animal behaviours and cognitive processes. Perisomatic GABAergic inhibition is prominently involved in cortical oscillations driven by ACh release from septal cholinergic afferents. In neocortex and hippocampal CA3 regions, parvalbumin (PV)‐expressing basket cells, activated by ACh and glutamatergic agonists, largely mediate oscillations. However, in CA1 hippocampus in vitro , cholinergic agonists or the optogenetic release of endogenous ACh from septal afferents induces rhythmic, theta‐frequency inhibitory postsynaptic currents (IPSCs) in pyramidal cells, even with glutamatergic transmission blocked. The IPSCs are regulated by exogenous and endogenous cannabinoids, suggesting that they arise from type 1 cannabinoid receptor‐expressing (CB1R+) interneurons – mainly cholecystokinin (CCK)‐expressing cells. Nevertheless, an occult contribution of PV‐expressing interneurons to these rhythms remained conceivable. Here, we directly test this hypothesis by selectively silencing CA1 PV‐expressing cells optogenetically with halorhodopsin or archaerhodopsin. However, this had no effect on theta‐frequency IPSC rhythms induced by carbachol (CCh). In contrast, the silencing of glutamic acid decarboxylase 2‐positive interneurons, which include the CCK‐expressing basket cells, strongly suppressed inhibitory oscillations; PV‐expressing interneurons appear to play no role. The low‐frequency IPSC oscillations induced by CCh or optogenetically stimulated ACh release were also inhibited by a μ‐opioid receptor (MOR) agonist, which was unexpected because MORs in CA1 are not usually associated with CCK‐expressing cells. Our results reveal novel properties of an inhibitory oscillator circuit within CA1 that is activated by muscarinic agonists. The oscillations could contribute to behaviourally relevant, atropine‐sensitive, theta rhythms and link cannabinoid and opioid actions functionally.

Divergent opioid-mediated suppression of inhibition between hippocampus and neocortex across species and development

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

Oxycodone Withdrawal Induces HDAC1/HDAC2-dependent Transcriptional Maladaptations in the Reward Pathway in a Mouse Model of Peripheral Nerve Injury

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Opioid Signal Transduction Regulates The Dendritic Morphology Of Somatostatin And Parvalbumin Interneurons In The Medial Prefrontal Cortex

Mu and Delta Opioid Receptors Modulate Inhibition within the Prefrontal Cortex through Dissociable Cellular and Molecular Mechanisms

Complex opioid driven modulation of glutamatergic and cholinergic neurotransmission in a GABAergic brain nucleus associated with emotion, reward and addiction.

In vivo reduction of hippocampal Caveolin-1 by RNA interference alters morphine addiction and neuroplasticity changes in male mice

Mimicking opioid analgesia in cortical pain circuits

μ-Opioid Receptor Modulation of the Glutamatergic/GABAergic Midbrain Inputs to the Mouse Dorsal Hippocampus

Morphine Coordinates SST and PV Interneurons in the Prelimbic Cortex to Disinhibit Pyramidal Neurons and Enhance Reward

A master regulator of opioid reward in the ventral prefrontal cortex

Neural circuit basis of adolescent THC-induced potentiation of opioid responses later in life

Neural basis of adolescent THC-induced potentiation of opioid responses later in life

Dentate gyrus μ-opioid receptor-mediated neurogenic processes are associated with alterations in morphine self-administration

Changes in Ensemble Activity of Hippocampus CA1 Neurons Induced by Chronic Morphine Administration in Freely Behaving Mice.

Optogenetic Identification of an Intrinsic Cholinergically Driven Inhibitory Oscillator Sensitive to Cannabinoids and Opioids in Hippocampal CA1

Endogenous opioids regulate moment-to-moment neuronal communication and excitability

CpH methylome analysis in human cortical neurons identifies novel gene pathways and drug targets for opioid use disorder

Development of Anxiety-Like Behavior Via Hippocampal IGF-2 Signaling in the Offspring of Parental Morphine Exposure: Effect of Enriched Environment

Neurod1 modulates opioid antinociceptive tolerance via two distinct mechanisms.